Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  204.37
-5.75 (-2.73%)
AAPL  269.36
+4.78 (1.81%)
AMD  196.18
-3.97 (-1.99%)
BAC  51.42
-1.64 (-3.09%)
GOOG  314.45
-0.44 (-0.14%)
META  643.51
-12.15 (-1.85%)
MSFT  387.23
-10.00 (-2.52%)
NVDA  191.54
+1.72 (0.91%)
ORCL  140.18
-7.91 (-5.34%)
TSLA  395.70
-16.12 (-3.91%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.